about
Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent.BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family historyThe CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers.Lifestyle Risk Factors for Breast Cancer in BRCA1/2-Mutation Carriers Around Childbearing Age.Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer.Ownership of uncertainty: healthcare professionals counseling and treating women from hereditary breast and ovarian cancer families who receive an inconclusive BRCA1/2 genetic test resultContribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer.Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriersOn the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk.Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect.In-silico insights on the prognostic potential of immune cell infiltration patterns in the breast lobular epithelium.Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest.Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis.The Dose-Response Effects of Aerobic Exercise on Body Composition and Breast Tissue among Women at High Risk for Breast Cancer: A Randomized Trial.Management of pregnant women with breast cancer.Detection of new point mutations of BRCA1 and BRCA2 in breast cancer patients.Dose-response effects of aerobic exercise on estrogen among women at high risk for breast cancer: a randomized controlled trial.Cancer Risk in Women Treated with Fertility Drugs According to Parity Status-A Registry-based Cohort Study.Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers.A genetic variant at 12p11 significantly modifies breast cancer risk in a genetically homogenous island population.A Novel Germline Mutation in BRCA1 Causes Exon 20 Skipping in a Korean Family with a History of Breast Cancer.Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: effects of oral contraceptive use and parental origin of mutation.Involvement of IGF-1R regulation by miR-515-5p modifies breast cancer risk among BRCA1 carriers.Body weight and risk of breast cancer in BRCA1/2 mutation carriers.The effect of oral 3,3'-diindolylmethane supplementation on the 2:16α-OHE ratio in BRCA1 mutation carriers.Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors.Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.Polymorphisms of the XRCC1 gene and breast cancer risk in the Mexican population.Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in and Pathogenic Variant Carriers
P2860
Q30426599-970EA8EA-3A5A-4E11-8EBC-7A85FC676BFDQ33327591-9AB3BB9D-8958-4A54-B7BD-4D82791851BBQ33330316-B46C90A3-690F-4FA0-9BA2-2C2AF2A77F56Q33675997-12DAE8A0-2C95-4B1C-8999-F93FFA7DB6DDQ33885464-9977F336-2CF1-475C-BDF8-C1722786DAA3Q33976413-A4B74991-D4EB-4BCC-90EB-ED07575B7DE4Q34722573-6C097E7B-D82D-4A68-8425-B296B5782A66Q36656262-BECA2BCD-A2D1-40CF-98A9-80FA8DE9D212Q36706659-25F47A2C-4276-484C-95FD-47B81596623DQ36800273-FC4385F0-A408-42CD-B660-E4EE2592943FQ36968289-C56A196C-F22B-4DAE-B3D0-B8F920E971F2Q37277957-F7DF40CB-2FAC-4373-8CE9-83EF58309991Q37380558-494AFA98-D6DF-4826-B9ED-EBB886BD7E17Q37426789-CA77EB22-F905-431E-8520-258F407D8058Q37700269-71B61CB3-BA05-4BFC-AC77-910369B07D13Q37845315-E7DA02EC-024F-4C2C-957B-A2F4C238C61DQ38904251-029BA959-1C47-459A-AAE0-0FDC0081911DQ38948954-CBBD9FC7-6827-4116-AB02-B437CDACDE09Q39008963-DD4547AC-4BB2-4672-BFA6-8E091369C4C9Q39699496-4145E251-9760-4EE2-95AE-EB4D58668B6BQ41725974-05FE646A-7636-40A9-A194-E7E8E7C7CC87Q42366737-B1039A4A-F92A-4467-8528-CA9CC72C5FBDQ43613940-36284CEB-51FA-4D8C-BD1A-E5F282A825ACQ44477999-040CEFFC-C17D-4DA5-B762-22A55E4B89EEQ47418222-85CA5F46-921A-4364-BFD1-0204C10ED3AAQ51062456-9F607F0D-E4E7-48FA-B3E6-C5C976BAA44FQ51145030-6E5E7BE7-10ED-487F-9CE0-83CE426DBAE1Q51692616-94BEAD27-A401-4E8A-8AA5-BF2547223AC2Q54173735-C66026CE-7B5E-4814-93F1-DFB4B3111A36Q54941261-DD2861C0-D5B3-447B-889C-E2852EBA2B7EQ59138109-B1E32D3C-DBF2-4454-9CB7-1A3CBE7D9E07
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Modifiers of risk of hereditary breast cancer.
@ast
Modifiers of risk of hereditary breast cancer.
@en
Modifiers of risk of hereditary breast cancer.
@nl
type
label
Modifiers of risk of hereditary breast cancer.
@ast
Modifiers of risk of hereditary breast cancer.
@en
Modifiers of risk of hereditary breast cancer.
@nl
prefLabel
Modifiers of risk of hereditary breast cancer.
@ast
Modifiers of risk of hereditary breast cancer.
@en
Modifiers of risk of hereditary breast cancer.
@nl
P2860
P356
P1433
P1476
Modifiers of risk of hereditary breast cancer.
@en
P2860
P2888
P304
P356
10.1038/SJ.ONC.1209870
P407
P577
2006-09-01T00:00:00Z
P5875
P6179
1014163684